Dual-Target Peptide-Modified Erythrocyte Membrane-Enveloped PLGA Nanoparticles for the Treatment of Glioma.

导出 LinkOut

翻译打印收藏纠错

作者： Yuexin,Cui ^[1] ; Jiejie,Sun ^[2] ; Wenyan,Hao ^[2] ; Mengyu,Chen ^[2] ; Yingzi,Wang ^[1] ; Fenghua,Xu ^[2] ; Chunsheng,Gao ^[1]

作者单位： School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China. ^[1] State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, China. ^[2] Department of Pharmacy, People's Liberation Army of China (PLA) General Hospital, Beijing, China. ^[3]

关键词 DWSW NGR biomimetic nanoparticles blood–brain barrier blood–brain tumor barrier dual-targeting euphorbia factor L1 glioma

DOI 10.3389/fonc.2020.563938

PMID 33194638

发布时间 2020-11-17

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in oncology

2020年10卷

563938页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Dual-Target Peptide-Modified Erythrocyte Membrane-Enveloped PLGA Nanoparticles for the Treatment of Glioma.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Dual-Target Peptide-Modified Erythrocyte Membrane-Enveloped PLGA Nanoparticles for the Treatment of Glioma.

Frontiers in oncology

相似文献

Frontiers in oncology

相关期刊

检索历史清除